Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsPhase4

Rotator Cuff Tears Repair With or Without Dermal Patch Augmentation

Sponsor: University Hospitals, Leicester

NCT ID: NCT04975581

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Access to the study treatment being tested
Type of study
Interventional (receives a drug or procedure)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Allograft Patch (biological)
How long the study runs
Study runs about 60 months (dates as stated)
About the drug or intervention
Allograft Patch — biological: Rotator Cuff repair with Allograft Patch (Graftjacket Now)
Patient visit burden
Not specified by the sponsor
Type of study
Testing a treatment
Ages
50 Years to 75 Years
Who
All
Number of participants
40
Started
2021-12-03
Last checked
2026-05

Plain English Summary

What is this study?

  • • Testing a new treatment for rotator cuff tears
  • • Phase4 - 40 participants
  • • The Investigators are planning to conduct a Pilot study of 40 patients of Pragmatic randomised controlled trial comparing rotator cuff tendons repair (small tendons around the shoulder ) with or without augmentative patch

Who can take part?

  • • Ages 50 Years to 75 Years
  • • Diagnosed with rotator cuff tears

Where?

  • • Leicester - University Hopsitals of Leicester NHS Trust

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

The Investigators are planning to conduct a Pilot study of 40 patients of Pragmatic randomised controlled trial comparing rotator cuff tendons repair (small tendons around the shoulder ) with or without augmentative patch. It includes patients between age groups 50 to 75 years with large (≥ 3cm and \< 5 cm ) rotator cuff tear that can be fully repaired using open or mini open repair with or without an augmentation with a human dermal matrix allograft (processed skin graft from a human donor ). The main aim is to examine whether the addition of the patch helps to reduce the rate of re-tear of the rotator cuff tendons at one year following surgery. Patients are randomized to receive either a repair with addition of an augmentative patch or a repair without a patch and have an identical follow-up after surgery. Patients are followed up in outpatient at 6 weeks , 3 months and 12 months after randomization and receive an Magnetic Resonant Imaging (MRI) scan 12 months after surgery. The primary outcome measure is to assess the Re-tear rate of rotator cuff at 12 months after surgery. The secondary outcome measure is to assess functional scores of the shoulder at 12 months . The tertiary outcome measures are to check the cost effectiveness of each procedure.

More detail

The Investigators are planning to conduct a Pilot study of 40 patients of Pragmatic randomised controlled trial comparing rotator cuff tendons repair (small tendons around the shoulder ) with or without augmentative patch. It includes patients between age groups 50 to 75 years with large (≥ 3cm and \< 5 cm ) rotator cuff tear that can be fully repaired using open or mini open repair with or without an augmentation with a human dermal matrix allograft (processed skin graft from a human donor ). The main aim is to examine whether the addition of the patch helps to reduce the rate of re-tear of the rotator cuff tendons at one year following surgery. Patients are randomized to receive either a repair with addition of an augmentative patch or a repair without a patch and have an identical follow-up after surgery. Patients are followed up in outpatient at 6 weeks , 3 months and 12 months after randomization and receive an Magnetic Resonant Imaging (MRI) scan 12 months after surgery. The primary outcome measure is to assess the Re-tear rate of rotator cuff at 12 months after surgery. The secondary outcome measure is to assess functional scores of the shoulder at 12 months . The tertiary outcome measures are to check the cost effectiveness of each procedure.

Rotator Cuff Tears

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 50 Years - 75 Years
  • Who can join: All genders

What the study is looking for

  • ✓Patient aged at least 50 years to 75 years.
  • ✓Degenerative cuff tear.
  • ✓Large Full thickness rotator cuff tear (≥ 3cm and \< 5 cm ) that is fully repairable.
  • ✓Tears diagnosed using MRI scan.
  • ✓Ability to consent.

Who cannot take part

  • ✗Previous surgery on the affected shoulder.
  • ✗Osteoarthritic changes.
  • ✗Unable to have MRI Scans.
  • ✗Significant neck pathology.
  • ✗Cognitive problems or language issue.
See the full criteria
Inclusion Criteria: 1. Patient aged at least 50 years to 75 years. 2. Degenerative cuff tear. 3. Large Full thickness rotator cuff tear (≥ 3cm and \< 5 cm ) that is fully repairable. 4. Tears diagnosed using MRI scan. 5. Ability to consent. 6. Agreement to use of human dermal matrix allograft as augmentative patch Exclusion Criteria: 1. Previous surgery on the affected shoulder. 2. Osteoarthritic changes. 3. Unable to have MRI Scans. 4. Significant neck pathology. 5. Cognitive problems or language issue. 6. Systemic arthritis 7. Significant dual pathology in the involved shoulder 8. Acute Traumatic tears (\< 6 months since injury).

Where Is This Study? (1 UK site)

University Hopsitals of Leicester NHS Trust

Leicester, United Kingdom

Recruiting
Site contact (verified)

How to Get in Touch

UHL Sponsor

Sponsor contact

CONTACT

+44 116 258 8239 (1823) uhlsponsor@uhl-tr.nhs.uk
Data sourced from ClinicalTrials.gov · Last verified: 2026-05